Dong Zou

USPTO Granted Patents = 15 (Patent Applications = 14)

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 9.7

ph-index = 9

Forward Citations = 186(Granted Patents)

Location History:

Newton, MA (US) (2008)
Concord, MA (US) (2004 - 2016)

Company Filing History:

10 out of 69

Ariad Pharmaceuticals, Inc.

patents

1 out of 1

Cubist Pharmacueticals, Inc.

Cubist Pharmaceuticals, Incorporated

patents

6. 1 out of 1

Araid Gene Therapeutics, Inc.

patent

Years Active: 2004-2016

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors (2016-03-08),

2. 9273077 - Phosphorus derivatives as kinase inhibitors (2016-03-01),

3. 9193729 - Inhibiting transient receptor potential ion channel TRPA1 (2015-11-24),

4. 9090561 - Acetylenic heteroaryl compounds (2015-07-28),

5. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors (2015-05-12),

6. 9012462 - Phosphorous derivatives as kinase inhibitors (2015-04-21),

7. 8809314 - Cephalosporin compound (2014-08-19),

8. 8778942 - Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors (2014-07-15),

9. 8470851 - Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors (2013-06-25),

10. 8461167 - Acetylenic heteroaryl compounds (2013-06-11),

11. 8278307 - Monocyclic Heteroaryl compounds (2012-10-02),

12. 8114874 - Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors (2012-02-14),

13. 7432277 - Phosphorus-containing macrocycles (2008-10-07),

14. 6936633 - Pyrrolidinone derivatives (2005-08-30),

15. 6727275 - Pyrrolidinone derivatives (2004-04-27),

Title: Innovations and Contributions of Inventor Dong Zou

Introduction

Dong Zou is a prominent inventor based in Concord, MA, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, he has made remarkable advancements in the development of kinase inhibitors, which play a crucial role in cancer treatment and other diseases.

Latest Patents

Among his latest patents, Dong Zou has developed substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors. This invention relates to compounds of the general formula that are designed to inhibit specific protein kinases. Additionally, he has worked on phosphorus derivatives as kinase inhibitors, featuring compounds of the general formula that are also aimed at inhibiting protein kinases.

Career Highlights

Throughout his career, Dong Zou has been associated with notable companies such as Ariad Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc. His work in these organizations has contributed to the advancement of innovative therapies in the pharmaceutical industry.

Collaborations

Dong Zou has collaborated with esteemed colleagues, including R Mathew Thomas and Yihan Wang, to further enhance his research and development efforts in the field of kinase inhibitors.

Conclusion

Dong Zou's innovative work and dedication to the field of pharmaceuticals have led to significant advancements in kinase inhibitors, showcasing his impact as an inventor. His contributions continue to influence the development of new therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.